Post-approval studies (Phase 4)Study completedNCT01408810
What this trial is testing
Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis
Who this might be right for
Ulcerative Colitis
Grupo de Estudo da Doença Inflamatória Intestinal 21